Financhill
Sell
44

GRDN Quote, Financials, Valuation and Earnings

Last price:
$29.20
Seasonality move :
-19.56%
Day range:
$29.17 - $29.82
52-week range:
$17.78 - $37.43
Dividend yield:
0%
P/E ratio:
46.06x
P/S ratio:
1.33x
P/B ratio:
10.10x
Volume:
189.4K
Avg. volume:
344K
1-year change:
18.37%
Market cap:
$1.9B
Revenue:
$1.2B
EPS (TTM):
$0.64

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
GRDN
Guardian Pharmacy Services, Inc.
$354.1M $0.24 15.2% 41.76% $34.00
BKD
Brookdale Senior Living, Inc.
$827.4M -$0.19 -3.5% -50.82% $11.44
ENSG
The Ensign Group, Inc.
$1.3B $1.61 20.72% 26.61% $207.20
LFST
Lifestance Health Group, Inc.
$355M $0.04 16.15% -95.93% $8.50
PACS
PACS Group, Inc.
$1.2B $0.47 13.51% 79.39% $35.00
PNTG
The Pennant Group, Inc.
$222.1M $0.29 46.42% 94.28% $34.67
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
GRDN
Guardian Pharmacy Services, Inc.
$29.32 $34.00 $1.9B 46.06x $0.00 0% 1.33x
BKD
Brookdale Senior Living, Inc.
$10.64 $11.44 $2.5B -- $0.00 0% 0.77x
ENSG
The Ensign Group, Inc.
$177.94 $207.20 $10.3B 31.67x $0.06 0.14% 2.15x
LFST
Lifestance Health Group, Inc.
$6.46 $8.50 $2.5B -- $0.00 0% 1.83x
PACS
PACS Group, Inc.
$31.49 $35.00 $4.9B 30.37x $0.00 0% 1.00x
PNTG
The Pennant Group, Inc.
$28.94 $34.67 $1B 38.25x $0.00 0% 1.21x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
GRDN
Guardian Pharmacy Services, Inc.
15.65% -0.109 2.04% 0.88x
BKD
Brookdale Senior Living, Inc.
100.12% -0.463 273.07% 0.46x
ENSG
The Ensign Group, Inc.
50.43% 1.312 21.59% 1.37x
LFST
Lifestance Health Group, Inc.
24.09% -0.061 22.14% 1.42x
PACS
PACS Group, Inc.
80.75% 1.669 171.05% 0.82x
PNTG
The Pennant Group, Inc.
48.47% 0.561 33.81% 0.90x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
GRDN
Guardian Pharmacy Services, Inc.
$74.7M $16.8M 19.18% 24.04% 4.46% $23M
BKD
Brookdale Senior Living, Inc.
$64.1M $18.3M -5.43% -202.37% 2.25% $34.9M
ENSG
The Ensign Group, Inc.
$163.6M $108.7M 8.27% 16.99% 8.39% $101.8M
LFST
Lifestance Health Group, Inc.
$103M $8M -0.47% -0.62% 2.19% $17M
PACS
PACS Group, Inc.
$188.8M $86.4M 3.89% 21.93% 6.42% $186.8M
PNTG
The Pennant Group, Inc.
$29.5M $13.3M 4.83% 9.98% 5.8% $10.5M

Guardian Pharmacy Services, Inc. vs. Competitors

  • Which has Higher Returns GRDN or BKD?

    Brookdale Senior Living, Inc. has a net margin of 2.54% compared to Guardian Pharmacy Services, Inc.'s net margin of -14.11%. Guardian Pharmacy Services, Inc.'s return on equity of 24.04% beat Brookdale Senior Living, Inc.'s return on equity of -202.37%.

    Company Gross Margin Earnings Per Share Invested Capital
    GRDN
    Guardian Pharmacy Services, Inc.
    19.8% $0.15 $229.6M
    BKD
    Brookdale Senior Living, Inc.
    7.88% -$0.48 $5.5B
  • What do Analysts Say About GRDN or BKD?

    Guardian Pharmacy Services, Inc. has a consensus price target of $34.00, signalling upside risk potential of 15.96%. On the other hand Brookdale Senior Living, Inc. has an analysts' consensus of $11.44 which suggests that it could grow by 7.5%. Given that Guardian Pharmacy Services, Inc. has higher upside potential than Brookdale Senior Living, Inc., analysts believe Guardian Pharmacy Services, Inc. is more attractive than Brookdale Senior Living, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    GRDN
    Guardian Pharmacy Services, Inc.
    3 0 0
    BKD
    Brookdale Senior Living, Inc.
    1 0 0
  • Is GRDN or BKD More Risky?

    Guardian Pharmacy Services, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Brookdale Senior Living, Inc. has a beta of 0.664, suggesting its less volatile than the S&P 500 by 33.606%.

  • Which is a Better Dividend Stock GRDN or BKD?

    Guardian Pharmacy Services, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Brookdale Senior Living, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Guardian Pharmacy Services, Inc. pays 128.01% of its earnings as a dividend. Brookdale Senior Living, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios GRDN or BKD?

    Guardian Pharmacy Services, Inc. quarterly revenues are $377.4M, which are smaller than Brookdale Senior Living, Inc. quarterly revenues of $813.2M. Guardian Pharmacy Services, Inc.'s net income of $9.6M is higher than Brookdale Senior Living, Inc.'s net income of -$114.7M. Notably, Guardian Pharmacy Services, Inc.'s price-to-earnings ratio is 46.06x while Brookdale Senior Living, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Guardian Pharmacy Services, Inc. is 1.33x versus 0.77x for Brookdale Senior Living, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    GRDN
    Guardian Pharmacy Services, Inc.
    1.33x 46.06x $377.4M $9.6M
    BKD
    Brookdale Senior Living, Inc.
    0.77x -- $813.2M -$114.7M
  • Which has Higher Returns GRDN or ENSG?

    The Ensign Group, Inc. has a net margin of 2.54% compared to Guardian Pharmacy Services, Inc.'s net margin of 6.47%. Guardian Pharmacy Services, Inc.'s return on equity of 24.04% beat The Ensign Group, Inc.'s return on equity of 16.99%.

    Company Gross Margin Earnings Per Share Invested Capital
    GRDN
    Guardian Pharmacy Services, Inc.
    19.8% $0.15 $229.6M
    ENSG
    The Ensign Group, Inc.
    12.62% $1.42 $4.3B
  • What do Analysts Say About GRDN or ENSG?

    Guardian Pharmacy Services, Inc. has a consensus price target of $34.00, signalling upside risk potential of 15.96%. On the other hand The Ensign Group, Inc. has an analysts' consensus of $207.20 which suggests that it could grow by 16.44%. Given that The Ensign Group, Inc. has higher upside potential than Guardian Pharmacy Services, Inc., analysts believe The Ensign Group, Inc. is more attractive than Guardian Pharmacy Services, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    GRDN
    Guardian Pharmacy Services, Inc.
    3 0 0
    ENSG
    The Ensign Group, Inc.
    3 1 0
  • Is GRDN or ENSG More Risky?

    Guardian Pharmacy Services, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison The Ensign Group, Inc. has a beta of 0.848, suggesting its less volatile than the S&P 500 by 15.196%.

  • Which is a Better Dividend Stock GRDN or ENSG?

    Guardian Pharmacy Services, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Ensign Group, Inc. offers a yield of 0.14% to investors and pays a quarterly dividend of $0.06 per share. Guardian Pharmacy Services, Inc. pays 128.01% of its earnings as a dividend. The Ensign Group, Inc. pays out 4.74% of its earnings as a dividend. The Ensign Group, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Guardian Pharmacy Services, Inc.'s is not.

  • Which has Better Financial Ratios GRDN or ENSG?

    Guardian Pharmacy Services, Inc. quarterly revenues are $377.4M, which are smaller than The Ensign Group, Inc. quarterly revenues of $1.3B. Guardian Pharmacy Services, Inc.'s net income of $9.6M is lower than The Ensign Group, Inc.'s net income of $83.9M. Notably, Guardian Pharmacy Services, Inc.'s price-to-earnings ratio is 46.06x while The Ensign Group, Inc.'s PE ratio is 31.67x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Guardian Pharmacy Services, Inc. is 1.33x versus 2.15x for The Ensign Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    GRDN
    Guardian Pharmacy Services, Inc.
    1.33x 46.06x $377.4M $9.6M
    ENSG
    The Ensign Group, Inc.
    2.15x 31.67x $1.3B $83.9M
  • Which has Higher Returns GRDN or LFST?

    Lifestance Health Group, Inc. has a net margin of 2.54% compared to Guardian Pharmacy Services, Inc.'s net margin of 0.3%. Guardian Pharmacy Services, Inc.'s return on equity of 24.04% beat Lifestance Health Group, Inc.'s return on equity of -0.62%.

    Company Gross Margin Earnings Per Share Invested Capital
    GRDN
    Guardian Pharmacy Services, Inc.
    19.8% $0.15 $229.6M
    LFST
    Lifestance Health Group, Inc.
    28.32% $0.00 $2B
  • What do Analysts Say About GRDN or LFST?

    Guardian Pharmacy Services, Inc. has a consensus price target of $34.00, signalling upside risk potential of 15.96%. On the other hand Lifestance Health Group, Inc. has an analysts' consensus of $8.50 which suggests that it could grow by 31.58%. Given that Lifestance Health Group, Inc. has higher upside potential than Guardian Pharmacy Services, Inc., analysts believe Lifestance Health Group, Inc. is more attractive than Guardian Pharmacy Services, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    GRDN
    Guardian Pharmacy Services, Inc.
    3 0 0
    LFST
    Lifestance Health Group, Inc.
    7 1 0
  • Is GRDN or LFST More Risky?

    Guardian Pharmacy Services, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Lifestance Health Group, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock GRDN or LFST?

    Guardian Pharmacy Services, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Lifestance Health Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Guardian Pharmacy Services, Inc. pays 128.01% of its earnings as a dividend. Lifestance Health Group, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios GRDN or LFST?

    Guardian Pharmacy Services, Inc. quarterly revenues are $377.4M, which are larger than Lifestance Health Group, Inc. quarterly revenues of $363.8M. Guardian Pharmacy Services, Inc.'s net income of $9.6M is higher than Lifestance Health Group, Inc.'s net income of $1.1M. Notably, Guardian Pharmacy Services, Inc.'s price-to-earnings ratio is 46.06x while Lifestance Health Group, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Guardian Pharmacy Services, Inc. is 1.33x versus 1.83x for Lifestance Health Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    GRDN
    Guardian Pharmacy Services, Inc.
    1.33x 46.06x $377.4M $9.6M
    LFST
    Lifestance Health Group, Inc.
    1.83x -- $363.8M $1.1M
  • Which has Higher Returns GRDN or PACS?

    PACS Group, Inc. has a net margin of 2.54% compared to Guardian Pharmacy Services, Inc.'s net margin of 3.89%. Guardian Pharmacy Services, Inc.'s return on equity of 24.04% beat PACS Group, Inc.'s return on equity of 21.93%.

    Company Gross Margin Earnings Per Share Invested Capital
    GRDN
    Guardian Pharmacy Services, Inc.
    19.8% $0.15 $229.6M
    PACS
    PACS Group, Inc.
    14.04% $0.32 $4.5B
  • What do Analysts Say About GRDN or PACS?

    Guardian Pharmacy Services, Inc. has a consensus price target of $34.00, signalling upside risk potential of 15.96%. On the other hand PACS Group, Inc. has an analysts' consensus of $35.00 which suggests that it could grow by 11.15%. Given that Guardian Pharmacy Services, Inc. has higher upside potential than PACS Group, Inc., analysts believe Guardian Pharmacy Services, Inc. is more attractive than PACS Group, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    GRDN
    Guardian Pharmacy Services, Inc.
    3 0 0
    PACS
    PACS Group, Inc.
    2 0 0
  • Is GRDN or PACS More Risky?

    Guardian Pharmacy Services, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison PACS Group, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock GRDN or PACS?

    Guardian Pharmacy Services, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. PACS Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Guardian Pharmacy Services, Inc. pays 128.01% of its earnings as a dividend. PACS Group, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios GRDN or PACS?

    Guardian Pharmacy Services, Inc. quarterly revenues are $377.4M, which are smaller than PACS Group, Inc. quarterly revenues of $1.3B. Guardian Pharmacy Services, Inc.'s net income of $9.6M is lower than PACS Group, Inc.'s net income of $52.3M. Notably, Guardian Pharmacy Services, Inc.'s price-to-earnings ratio is 46.06x while PACS Group, Inc.'s PE ratio is 30.37x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Guardian Pharmacy Services, Inc. is 1.33x versus 1.00x for PACS Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    GRDN
    Guardian Pharmacy Services, Inc.
    1.33x 46.06x $377.4M $9.6M
    PACS
    PACS Group, Inc.
    1.00x 30.37x $1.3B $52.3M
  • Which has Higher Returns GRDN or PNTG?

    The Pennant Group, Inc. has a net margin of 2.54% compared to Guardian Pharmacy Services, Inc.'s net margin of 3.01%. Guardian Pharmacy Services, Inc.'s return on equity of 24.04% beat The Pennant Group, Inc.'s return on equity of 9.98%.

    Company Gross Margin Earnings Per Share Invested Capital
    GRDN
    Guardian Pharmacy Services, Inc.
    19.8% $0.15 $229.6M
    PNTG
    The Pennant Group, Inc.
    12.87% $0.17 $645.9M
  • What do Analysts Say About GRDN or PNTG?

    Guardian Pharmacy Services, Inc. has a consensus price target of $34.00, signalling upside risk potential of 15.96%. On the other hand The Pennant Group, Inc. has an analysts' consensus of $34.67 which suggests that it could grow by 19.79%. Given that The Pennant Group, Inc. has higher upside potential than Guardian Pharmacy Services, Inc., analysts believe The Pennant Group, Inc. is more attractive than Guardian Pharmacy Services, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    GRDN
    Guardian Pharmacy Services, Inc.
    3 0 0
    PNTG
    The Pennant Group, Inc.
    5 0 0
  • Is GRDN or PNTG More Risky?

    Guardian Pharmacy Services, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison The Pennant Group, Inc. has a beta of 1.311, suggesting its more volatile than the S&P 500 by 31.126%.

  • Which is a Better Dividend Stock GRDN or PNTG?

    Guardian Pharmacy Services, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Pennant Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Guardian Pharmacy Services, Inc. pays 128.01% of its earnings as a dividend. The Pennant Group, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios GRDN or PNTG?

    Guardian Pharmacy Services, Inc. quarterly revenues are $377.4M, which are larger than The Pennant Group, Inc. quarterly revenues of $229M. Guardian Pharmacy Services, Inc.'s net income of $9.6M is higher than The Pennant Group, Inc.'s net income of $6.9M. Notably, Guardian Pharmacy Services, Inc.'s price-to-earnings ratio is 46.06x while The Pennant Group, Inc.'s PE ratio is 38.25x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Guardian Pharmacy Services, Inc. is 1.33x versus 1.21x for The Pennant Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    GRDN
    Guardian Pharmacy Services, Inc.
    1.33x 46.06x $377.4M $9.6M
    PNTG
    The Pennant Group, Inc.
    1.21x 38.25x $229M $6.9M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 62x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 38x

Buy
63
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 40x

Alerts

Buy
54
SMX alert for Dec 5

SMX (Security Matters) Plc [SMX] is up 71.88% over the past day.

Sell
15
HOV alert for Dec 5

Hovnanian Enterprises, Inc. [HOV] is up 1.22% over the past day.

Buy
67
NUTX alert for Dec 5

Nutex Health, Inc. [NUTX] is down 0.5% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock